Five-year  ||| S:0 E:10 ||| JJ
experience  ||| S:10 E:21 ||| NN
with  ||| S:21 E:26 ||| IN
mini-volume  ||| S:26 E:38 ||| JJ
priming  ||| S:38 E:46 ||| NN
in  ||| S:46 E:49 ||| IN
infants  ||| S:49 E:57 ||| CD
≤5  ||| S:57 E:60 ||| CD
kg ||| S:60 E:62 ||| NNS
:  ||| S:62 E:64 ||| :
safety  ||| S:64 E:71 ||| NN
of  ||| S:71 E:74 ||| IN
significantly  ||| S:74 E:88 ||| RB
smaller  ||| S:88 E:96 ||| JJR
transfusion  ||| S:96 E:108 ||| NN
volumes  ||| S:108 E:116 ||| NNS
Reducing  ||| S:116 E:125 ||| VBG
the  ||| S:125 E:129 ||| DT
cardiopulmonary  ||| S:129 E:145 ||| JJ
bypass  ||| S:145 E:152 ||| NNS
( ||| S:152 E:153 ||| -LRB-
CPB ||| S:153 E:156 ||| NNP
)  ||| S:156 E:158 ||| -RRB-
priming  ||| S:158 E:166 ||| JJ
volume  ||| S:166 E:173 ||| NN
in  ||| S:173 E:176 ||| IN
congenital  ||| S:176 E:187 ||| JJ
cardiac  ||| S:187 E:195 ||| JJ
surgery  ||| S:195 E:203 ||| NN
is  ||| S:203 E:206 ||| VBZ
important  ||| S:206 E:216 ||| JJ
because  ||| S:216 E:224 ||| IN
it  ||| S:224 E:227 ||| PRP
is  ||| S:227 E:230 ||| VBZ
associated  ||| S:230 E:241 ||| VBN
with  ||| S:241 E:246 ||| IN
fewer  ||| S:246 E:252 ||| JJR
transfusions ||| S:252 E:264 ||| NNS
.  ||| S:264 E:266 ||| .
This  ||| S:266 E:271 ||| DT
retrospective  ||| S:271 E:285 ||| JJ
study  ||| S:285 E:291 ||| NN
was  ||| S:291 E:295 ||| VBD
designed  ||| S:295 E:304 ||| VBN
to  ||| S:304 E:307 ||| TO
compare  ||| S:307 E:315 ||| VB
safety  ||| S:315 E:322 ||| NN
and  ||| S:322 E:326 ||| CC
transfusion  ||| S:326 E:338 ||| JJ
volumes  ||| S:338 E:346 ||| NNS
between  ||| S:346 E:354 ||| IN
the  ||| S:354 E:358 ||| DT
mini-volume  ||| S:358 E:370 ||| JJ
priming  ||| S:370 E:378 ||| NNS
( ||| S:378 E:379 ||| -LRB-
MP ||| S:379 E:381 ||| NNP
)  ||| S:381 E:383 ||| -RRB-
and  ||| S:383 E:387 ||| CC
conventional  ||| S:387 E:400 ||| JJ
priming  ||| S:400 E:408 ||| NNS
( ||| S:408 E:409 ||| -LRB-
CP ||| S:409 E:411 ||| NNP
)  ||| S:411 E:413 ||| -RRB-
methods ||| S:413 E:420 ||| NNS
.  ||| S:420 E:422 ||| .
Between  ||| S:422 E:430 ||| IN
2007  ||| S:430 E:435 ||| CD
and  ||| S:435 E:439 ||| CC
2012 ||| S:439 E:443 ||| CD
,  ||| S:443 E:445 ||| ,
congenital  ||| S:445 E:456 ||| JJ
heart  ||| S:456 E:462 ||| NN
surgery  ||| S:462 E:470 ||| NN
using  ||| S:470 E:476 ||| VBG
CPB  ||| S:476 E:480 ||| NNP
was  ||| S:480 E:484 ||| VBD
performed  ||| S:484 E:494 ||| VBN
on  ||| S:494 E:497 ||| IN
480  ||| S:497 E:501 ||| CD
infants  ||| S:501 E:509 ||| NNS
( ||| S:509 E:510 ||| -LRB-
≤5  ||| S:510 E:513 ||| FW
kg ||| S:513 E:515 ||| FW
) ||| S:515 E:516 ||| -RRB-
:  ||| S:516 E:518 ||| :
the  ||| S:518 E:522 ||| DT
MP  ||| S:522 E:525 ||| NNP
method  ||| S:525 E:532 ||| NN
was  ||| S:532 E:536 ||| VBD
used  ||| S:536 E:541 ||| VBN
in  ||| S:541 E:544 ||| IN
331  ||| S:544 E:548 ||| CD
infants  ||| S:548 E:556 ||| NNS
( ||| S:556 E:557 ||| -LRB-
MP  ||| S:557 E:560 ||| NNP
group ||| S:560 E:565 ||| NN
,  ||| S:565 E:567 ||| ,
69.0 ||| S:567 E:571 ||| CD
% ||| S:571 E:572 ||| NN
) ||| S:572 E:573 ||| -RRB-
,  ||| S:573 E:575 ||| ,
and  ||| S:575 E:579 ||| CC
the  ||| S:579 E:583 ||| DT
CP  ||| S:583 E:586 ||| NNP
method  ||| S:586 E:593 ||| NN
was  ||| S:593 E:597 ||| VBD
used  ||| S:597 E:602 ||| VBN
in  ||| S:602 E:605 ||| IN
149  ||| S:605 E:609 ||| CD
infants  ||| S:609 E:617 ||| NNS
( ||| S:617 E:618 ||| -LRB-
CP  ||| S:618 E:621 ||| NNP
group ||| S:621 E:626 ||| NN
,  ||| S:626 E:628 ||| ,
31.0 ||| S:628 E:632 ||| CD
% ||| S:632 E:633 ||| NN
) ||| S:633 E:634 ||| -RRB-
.  ||| S:634 E:636 ||| .
In  ||| S:636 E:639 ||| IN
the  ||| S:639 E:643 ||| DT
MP  ||| S:643 E:646 ||| NNP
group ||| S:646 E:651 ||| NN
,  ||| S:651 E:653 ||| ,
narrow-caliber  ||| S:653 E:668 ||| NNP
( ||| S:668 E:669 ||| -LRB-
3 ||| S:669 E:670 ||| CD
/ ||| S:670 E:671 ||| CD
16″ ||| S:671 E:674 ||| CD
)  ||| S:674 E:676 ||| -RRB-
tubing  ||| S:676 E:683 ||| NN
was  ||| S:683 E:687 ||| VBD
used ||| S:687 E:691 ||| VBN
,  ||| S:691 E:693 ||| ,
and  ||| S:693 E:697 ||| CC
the  ||| S:697 E:701 ||| DT
pump  ||| S:701 E:706 ||| JJ
heads  ||| S:706 E:712 ||| NNS
were  ||| S:712 E:717 ||| VBD
vertically  ||| S:717 E:728 ||| RB
aligned  ||| S:728 E:736 ||| VBN
to  ||| S:736 E:739 ||| TO
shorten  ||| S:739 E:747 ||| VB
the  ||| S:747 E:751 ||| DT
tubing  ||| S:751 E:758 ||| JJ
lengths ||| S:758 E:765 ||| NNS
.  ||| S:765 E:767 ||| .
The  ||| S:767 E:771 ||| DT
smallest  ||| S:771 E:780 ||| JJS
possible  ||| S:780 E:789 ||| JJ
oxygenators  ||| S:789 E:801 ||| NN
and  ||| S:801 E:805 ||| CC
hemofilters  ||| S:805 E:817 ||| NNS
were  ||| S:817 E:822 ||| VBD
used ||| S:822 E:826 ||| VBN
,  ||| S:826 E:828 ||| ,
and  ||| S:828 E:832 ||| CC
vacuum  ||| S:832 E:839 ||| JJ
drainage  ||| S:839 E:848 ||| NN
was  ||| S:848 E:852 ||| VBD
applied ||| S:852 E:859 ||| VBN
.  ||| S:859 E:861 ||| .
Ultrafiltration  ||| S:861 E:877 ||| NNP
was  ||| S:877 E:881 ||| VBD
vigorously  ||| S:881 E:892 ||| RB
applied  ||| S:892 E:900 ||| VBN
during  ||| S:900 E:907 ||| IN
CPB  ||| S:907 E:911 ||| NNP
to  ||| S:911 E:914 ||| TO
avoid  ||| S:914 E:920 ||| VB
excessive  ||| S:920 E:930 ||| JJ
hemodilution ||| S:930 E:942 ||| NN
.  ||| S:942 E:944 ||| .
The  ||| S:944 E:948 ||| DT
mean  ||| S:948 E:953 ||| JJ
age  ||| S:953 E:957 ||| NN
and  ||| S:957 E:961 ||| CC
body  ||| S:961 E:966 ||| NN
weight  ||| S:966 E:973 ||| NN
of  ||| S:973 E:976 ||| IN
the  ||| S:976 E:980 ||| DT
patients  ||| S:980 E:989 ||| NNS
were  ||| S:989 E:994 ||| VBD
48  ||| S:994 E:997 ||| CD
±  ||| S:997 E:999 ||| CD
41  ||| S:999 E:1002 ||| CD
( ||| S:1002 E:1003 ||| -LRB-
0-306 ||| S:1003 E:1008 ||| NNP
)  ||| S:1008 E:1010 ||| -RRB-
days  ||| S:1010 E:1015 ||| NNS
and  ||| S:1015 E:1019 ||| CC
3.8  ||| S:1019 E:1023 ||| CD
±  ||| S:1023 E:1025 ||| CD
0.8  ||| S:1025 E:1029 ||| CD
( ||| S:1029 E:1030 ||| -LRB-
1.3-5.0 ||| S:1030 E:1037 ||| NNP
)  ||| S:1037 E:1039 ||| -RRB-
kg ||| S:1039 E:1041 ||| NN
,  ||| S:1041 E:1043 ||| ,
respectively ||| S:1043 E:1055 ||| RB
.  ||| S:1055 E:1057 ||| .
The  ||| S:1057 E:1061 ||| DT
total  ||| S:1061 E:1067 ||| JJ
priming  ||| S:1067 E:1075 ||| NN
and  ||| S:1075 E:1079 ||| CC
transfusion  ||| S:1079 E:1091 ||| JJ
volumes  ||| S:1091 E:1099 ||| NNS
during  ||| S:1099 E:1106 ||| IN
CPB  ||| S:1106 E:1110 ||| NNP
were  ||| S:1110 E:1115 ||| VBD
lower  ||| S:1115 E:1121 ||| JJR
in  ||| S:1121 E:1124 ||| IN
the  ||| S:1124 E:1128 ||| DT
MP  ||| S:1128 E:1131 ||| NNP
group  ||| S:1131 E:1137 ||| NN
than  ||| S:1137 E:1142 ||| IN
in  ||| S:1142 E:1145 ||| IN
the  ||| S:1145 E:1149 ||| DT
CP  ||| S:1149 E:1152 ||| NNP
group  ||| S:1152 E:1158 ||| NN
( ||| S:1158 E:1159 ||| -LRB-
141  ||| S:1159 E:1163 ||| FW
±  ||| S:1163 E:1165 ||| FW
24  ||| S:1165 E:1168 ||| FW
mL  ||| S:1168 E:1171 ||| FW
vs.  ||| S:1171 E:1175 ||| FW
292  ||| S:1175 E:1179 ||| FW
±  ||| S:1179 E:1181 ||| FW
50  ||| S:1181 E:1184 ||| FW
mL ||| S:1184 E:1186 ||| FW
,  ||| S:1186 E:1188 ||| ,
P    ||| S:1188 E:1190 ||| NNP
< ||| S:1190 E:1191 ||| SYM
0.001 ||| S:1192 E:1197 ||| NNP
,  ||| S:1197 E:1199 ||| ,
and  ||| S:1199 E:1203 ||| CC
82  ||| S:1203 E:1206 ||| FW
±  ||| S:1206 E:1208 ||| FW
40  ||| S:1208 E:1211 ||| FW
mL  ||| S:1211 E:1214 ||| FW
vs.  ||| S:1214 E:1218 ||| FW
162  ||| S:1218 E:1222 ||| FW
±  ||| S:1222 E:1224 ||| FW
82  ||| S:1224 E:1227 ||| FW
mL ||| S:1227 E:1229 ||| FW
,  ||| S:1229 E:1231 ||| ,
P    ||| S:1231 E:1233 ||| NNP
< ||| S:1233 E:1234 ||| SYM
0.001 ||| S:1235 E:1240 ||| NNP
,  ||| S:1240 E:1242 ||| ,
respectively ||| S:1242 E:1254 ||| RB
) ||| S:1254 E:1255 ||| -RRB-
.  ||| S:1255 E:1257 ||| .
In  ||| S:1257 E:1260 ||| IN
the  ||| S:1260 E:1264 ||| DT
MP  ||| S:1264 E:1267 ||| NNP
group ||| S:1267 E:1272 ||| NN
,  ||| S:1272 E:1274 ||| ,
the  ||| S:1274 E:1278 ||| DT
smallest  ||| S:1278 E:1287 ||| JJS
priming  ||| S:1287 E:1295 ||| JJ
volume  ||| S:1295 E:1302 ||| NN
was  ||| S:1302 E:1306 ||| VBD
110  ||| S:1306 E:1310 ||| CD
mL ||| S:1310 E:1312 ||| NN
.  ||| S:1312 E:1314 ||| .
However ||| S:1314 E:1321 ||| RB
,  ||| S:1321 E:1323 ||| ,
there  ||| S:1323 E:1329 ||| EX
was  ||| S:1329 E:1333 ||| VBD
no  ||| S:1333 E:1336 ||| DT
significant  ||| S:1336 E:1348 ||| JJ
difference  ||| S:1348 E:1359 ||| NN
in  ||| S:1359 E:1362 ||| IN
the  ||| S:1362 E:1366 ||| DT
lowest  ||| S:1366 E:1373 ||| JJS
hematocrit  ||| S:1373 E:1384 ||| JJ
level  ||| S:1384 E:1390 ||| NN
during  ||| S:1390 E:1397 ||| IN
CPB  ||| S:1397 E:1401 ||| NNP
between  ||| S:1401 E:1409 ||| IN
the  ||| S:1409 E:1413 ||| DT
two  ||| S:1413 E:1417 ||| CD
groups  ||| S:1417 E:1424 ||| NNS
( ||| S:1424 E:1425 ||| -LRB-
22  ||| S:1425 E:1428 ||| CD
±  ||| S:1428 E:1430 ||| CD
3 ||| S:1430 E:1431 ||| CD
%  ||| S:1431 E:1433 ||| NN
vs.  ||| S:1433 E:1437 ||| IN
22  ||| S:1437 E:1440 ||| CD
±  ||| S:1440 E:1442 ||| CD
3 ||| S:1442 E:1443 ||| CD
% ||| S:1443 E:1444 ||| NN
,  ||| S:1444 E:1446 ||| ,
P  ||| S:1446 E:1448 ||| CD
=  ||| S:1448 E:1450 ||| CD
0.724 ||| S:1450 E:1455 ||| CD
) ||| S:1455 E:1456 ||| -RRB-
.  ||| S:1456 E:1458 ||| .
The  ||| S:1458 E:1462 ||| DT
incidence  ||| S:1462 E:1472 ||| NN
of  ||| S:1472 E:1475 ||| IN
postoperative  ||| S:1475 E:1489 ||| JJ
neurological  ||| S:1489 E:1502 ||| JJ
complications  ||| S:1502 E:1516 ||| NNS
was  ||| S:1516 E:1520 ||| VBD
not  ||| S:1520 E:1524 ||| RB
significantly  ||| S:1524 E:1538 ||| RB
different  ||| S:1538 E:1548 ||| JJ
between  ||| S:1548 E:1556 ||| IN
the  ||| S:1556 E:1560 ||| DT
MP  ||| S:1560 E:1563 ||| NNP
and  ||| S:1563 E:1567 ||| CC
CP  ||| S:1567 E:1570 ||| NNP
groups  ||| S:1570 E:1577 ||| NNS
( ||| S:1577 E:1578 ||| -LRB-
1.8 ||| S:1578 E:1581 ||| CD
%  ||| S:1581 E:1583 ||| NN
vs.  ||| S:1583 E:1587 ||| IN
2.7 ||| S:1587 E:1590 ||| CD
% ||| S:1590 E:1591 ||| NN
,  ||| S:1591 E:1593 ||| ,
P  ||| S:1593 E:1595 ||| CD
=  ||| S:1595 E:1597 ||| CD
0.509 ||| S:1597 E:1602 ||| CD
) ||| S:1602 E:1603 ||| -RRB-
.  ||| S:1603 E:1605 ||| .
After  ||| S:1605 E:1611 ||| IN
adjustment  ||| S:1611 E:1622 ||| NN
for  ||| S:1622 E:1626 ||| IN
the  ||| S:1626 E:1630 ||| DT
Risk  ||| S:1630 E:1635 ||| NNP
Adjustment  ||| S:1635 E:1646 ||| NNP
for  ||| S:1646 E:1650 ||| IN
Congenital  ||| S:1650 E:1661 ||| NNP
Heart  ||| S:1661 E:1667 ||| NNP
Surgery  ||| S:1667 E:1675 ||| NNP
category ||| S:1675 E:1683 ||| NN
,  ||| S:1683 E:1685 ||| ,
body  ||| S:1685 E:1690 ||| NN
surface  ||| S:1690 E:1698 ||| NN
area ||| S:1698 E:1702 ||| NN
,  ||| S:1702 E:1704 ||| ,
and  ||| S:1704 E:1708 ||| CC
age ||| S:1708 E:1711 ||| NN
,  ||| S:1711 E:1713 ||| ,
MP  ||| S:1713 E:1716 ||| NNP
was  ||| S:1716 E:1720 ||| VBD
not  ||| S:1720 E:1724 ||| RB
an  ||| S:1724 E:1727 ||| DT
independent  ||| S:1727 E:1739 ||| JJ
risk  ||| S:1739 E:1744 ||| NN
factor  ||| S:1744 E:1751 ||| NN
of  ||| S:1751 E:1754 ||| IN
postoperative  ||| S:1754 E:1768 ||| JJ
neurological  ||| S:1768 E:1781 ||| JJ
complications  ||| S:1781 E:1795 ||| NNS
or  ||| S:1795 E:1798 ||| CC
early  ||| S:1798 E:1804 ||| JJ
mortality  ||| S:1804 E:1814 ||| NN
( ||| S:1814 E:1815 ||| -LRB-
P  ||| S:1815 E:1817 ||| NNP
=  ||| S:1817 E:1819 ||| NNP
0.213  ||| S:1819 E:1825 ||| NNP
and  ||| S:1825 E:1829 ||| CC
P  ||| S:1829 E:1831 ||| CD
=  ||| S:1831 E:1833 ||| CD
0.467 ||| S:1833 E:1838 ||| CD
,  ||| S:1838 E:1840 ||| ,
respectively ||| S:1840 E:1852 ||| RB
) ||| S:1852 E:1853 ||| -RRB-
.  ||| S:1853 E:1855 ||| .
The  ||| S:1855 E:1859 ||| DT
MP  ||| S:1859 E:1862 ||| NNP
method  ||| S:1862 E:1869 ||| NN
reduced  ||| S:1869 E:1877 ||| VBD
the  ||| S:1877 E:1881 ||| DT
priming  ||| S:1881 E:1889 ||| JJ
volume  ||| S:1889 E:1896 ||| NN
to  ||| S:1896 E:1899 ||| TO
approximately  ||| S:1899 E:1913 ||| RB
140  ||| S:1913 E:1917 ||| CD
mL  ||| S:1917 E:1920 ||| NN
without  ||| S:1920 E:1928 ||| IN
increasing  ||| S:1928 E:1939 ||| VBG
the  ||| S:1939 E:1943 ||| DT
risk  ||| S:1943 E:1948 ||| NN
of  ||| S:1948 E:1951 ||| IN
morbidity  ||| S:1951 E:1961 ||| NN
or  ||| S:1961 E:1964 ||| CC
mortality  ||| S:1964 E:1974 ||| NN
in  ||| S:1974 E:1977 ||| IN
infants  ||| S:1977 E:1985 ||| CD
≤5  ||| S:1985 E:1988 ||| CD
kg ||| S:1988 E:1990 ||| NNS
.  ||| S:1990 E:1992 ||| .
The  ||| S:1992 E:1996 ||| DT
total  ||| S:1996 E:2002 ||| JJ
transfusion  ||| S:2002 E:2014 ||| NN
volume  ||| S:2014 E:2021 ||| NN
during  ||| S:2021 E:2028 ||| IN
CPB  ||| S:2028 E:2032 ||| NNP
was  ||| S:2032 E:2036 ||| VBD
reduced  ||| S:2036 E:2044 ||| VBN
by  ||| S:2044 E:2047 ||| IN
50 ||| S:2047 E:2049 ||| CD
%  ||| S:2049 E:2051 ||| NN
without  ||| S:2051 E:2059 ||| IN
compromising  ||| S:2059 E:2072 ||| VBG
hematocrit  ||| S:2072 E:2083 ||| JJ
levels ||| S:2083 E:2089 ||| NNS
.  ||| S:2089 E:2091 ||| .
We  ||| S:2091 E:2094 ||| PRP
recommend  ||| S:2094 E:2104 ||| VBP
the  ||| S:2104 E:2108 ||| DT
use  ||| S:2108 E:2112 ||| NN
of  ||| S:2112 E:2115 ||| IN
mini-volume  ||| S:2115 E:2127 ||| JJ
priming ||| S:2127 E:2134 ||| NN
,  ||| S:2134 E:2136 ||| ,
which  ||| S:2136 E:2142 ||| WDT
is  ||| S:2142 E:2145 ||| VBZ
a  ||| S:2145 E:2147 ||| DT
safe  ||| S:2147 E:2152 ||| JJ
and  ||| S:2152 E:2156 ||| CC
effective  ||| S:2156 E:2166 ||| JJ
method  ||| S:2166 E:2173 ||| NN
for  ||| S:2173 E:2177 ||| IN
reducing  ||| S:2177 E:2186 ||| VBG
transfusion  ||| S:2186 E:2198 ||| JJ
volumes ||| S:2198 E:2205 ||| NNS
.  ||| S:2205 E:2207 ||| .
